[The management of hyperlipoproteinemia with Liproreduct].
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007294:Inositol / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010919:Placebos; D013997:Time Factors
D004338:Drug Combinations; D000960:Hypolipidemic Agents; D009539:Nicotinic Acids; D010919:Placebos; D007294:Inositol; D002994:Clofibrate
Zur Behandlung von Hyperlipoproteinämien mit Liporeduct